• SOM Alumni Association
• University Health Care
• Join our Team
• Contact Us

• About Us
  • Physicians and Staff
• Academics & Education
• Research
  • Funding
  • Amsbury Lab
  • Amsbury Lab Members
  • Lab Collaborators
• Outreach
  • Run for Ovarian Cancer
  • Skatba's Annual Ride for Ovarian Cancer

Research

Gyn Oncology Clinical Trials

Through clinical trials, the physicians and scientists in the Division of Gynecologic Oncology at the University of Utah and Huntsman Cancer Institute, in cooperation with other institutions, work to find better ways to prevent, diagnose or treat cancers of the female reproductive system.  These research studies help doctors find ways to improve health and cancer care.

Amsbury Lab

Professor MARGIT M. JANÁT-AMSBURY focuses on the development of novel polymeric drug-, and gene carriers for clinical use in cancer therapy focusing mainly on gynecological malignancies. Her laboratory specializes in the design and development of innovative delivery systems and linking the areas of nano-medicine, macromolecular drug delivery, pharmaceutics and bioengineering to clinical applications. Delivery systems investigated by the Janát-Amsbury group are tailored to the tumor immunology of gynecological malignancies, including breast cancer and also target other areas of interest from the broad field of Obstetrics and Gynecology, including reproductive endocrinology and infertility, maternal fetal medicine as well as benign conditions as uterine fibroids and endometrioses.

Prof. Janát-Amsbury’s research aims to develop novel diagnostic and therapeutic tools specifically for ovarian, endometrial and cervical cancer. She has extensive clinical trial experience in oncology as an investigator and as a clinician in Europe and the United States and also held appointments at the University of Maastricht in the Netherlands and at Baylor College of Medicine in Houston, Texas, where she focused on translational research, being a lead-investigator in the first ever in humans applied polymeric IL-12 delivery system conducting a Phase 1 clinical trial in humans treating patients with recurrent ovarian cancer under a gene therapy protocol she developed.